Cloning and Overexpression of TGF-β1 cDNA in a Mammary Adenocarcinoma: In Vitro and In Vivo Effects

References

• Antonelli‐Orlidge A., Saunders K. B., Smith S. R., D'Amore P. A. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes. Proc. Natl. Acad. Sci. USA 1989; 86: 4544–4548
   PubMed Web of Science ®Google Scholar
• Anzano M. A., Roberts A. B., De Larco J. E., Wakefield L. M., Assoin R. K., Roche N. S., Smith J. M., Lazarus J. E., Sporn M. B. Increased secretion of type β transforming growth factor accompanies viral transformation of cells. Mol. Cell. Biol 1985; 5: 242–247
   PubMed Web of Science ®Google Scholar
• Arteaga C. L., Coffey R. J., Jr., Dugger T. C., McCutchen C. M., Moses H. L., Lyons R. M. Growth stimulation of human breast cancer cells with anti‐transforming growth factor β antibodies: evidence for negative autocrine regulation by transforming growth factor β. Cell Growth & Differentiation 1990; 1: 367–374
   PubMedGoogle Scholar
• Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. Wiley and Sons, New York 1988
   Google Scholar
• Aviv H., Leder P. Purification of biologically active globin messenger RNA by chromatography on oligo‐thymidylic acid cellulose. Proc. Natl. Acad. Sci. (USA) 1972; 69: 1408–2412
   PubMed Web of Science ®Google Scholar
• Barnard J. A., Lyons R. M., Moses H. L. The cell biology of transforming growth factor β. Bioch. Biophys. Accta 1990; 1032: 79–87
   PubMed Web of Science ®Google Scholar
• Brown P. D., Wakefield L. M., Levinson A. D., Sporn M. B. Physiochemical activation of recombinant latent transforming growth factor‐betas 1, 2, and 3. Growth Factors 1990; 3: 35–43
   PubMed Web of Science ®Google Scholar
• Brunner A. M., Gentry L. E., Cooper J. A., Purcho A. F. Recombinant type 1 transforming growth factor β precursor produced in Chinese hamster ovary cells is glycosylated and phosphorylated. Mol. Cell Biol 1988; 8: 2229–2232
   PubMedGoogle Scholar
• Carlow D. A., Kerbel R. S., Feltis J. T., Elliott B. E. Enhanced expression of class 1 MHC (Dk) gene products on immunogenic variants of a spontaneous murine carcinoma. JNCI 1985; 75: 291–301
   PubMedGoogle Scholar
• Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Cleveland D. W., Lopata M. A., MacDonald R. J., Cowan N. J., Rutter W. J., Kirschner M. W. Number and evolutionary conservation of alpha‐ and beta‐tubulin and cytoplasmic beta‐ and gamma‐actin genes using specific cloned cDNA probes. Cell 1980; 20: 95–105
   PubMed Web of Science ®Google Scholar
• Colletta A. A., Wakefield L. M., Howell F. V., Danielpour D., Baum M., Sporn M. B. The growth induction of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor beta. J. Clin. Invest 1991; 87: 277–283
   PubMed Web of Science ®Google Scholar
• DeLarco J. E., Todaro G. J. Growth factors from murine sarcoma virus‐transformed cells. Proc. Natl. Acad. Sci. (USA) 1978; 75: 4001–4005
   PubMed Web of Science ®Google Scholar
• Derynck R., Jarrett J. A., Chen E. Y., Eaton D. H., Bell J. R., Assoian R. K., Roberts A. B., Sporn M. B., Goeddel D. V. Human transforming growth factor‐β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–705
   PubMed Web of Science ®Google Scholar
• Dickson R. B., Kasid A., Huff K. K., Bates S. E., Knabbe C., Bronzert D., Gelmann E. P., Lippman M. E. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β‐estradiol or V‐Ha‐ras onco‐gene. Proc. Natl. Acad. Sci. (USA) 1987; 84: 837–841
   PubMed Web of Science ®Google Scholar
• Gentry L. E., Lioubin M. N., Purchio A. F., Marquardt H. Molecular events in the processing of recombi‐nant type 1 pre‐pro‐transforming growth factor β to the mature polypeptide. Mol. Cell. Biol 1988; 8: 4162–4168
   PubMed Web of Science ®Google Scholar
• Gluzman Y. SV40‐transformed simian cell support the replication of early SV40 mutants. Cell 1981; 23: 175–182
   PubMed Web of Science ®Google Scholar
• Gorman C. M., Merlino G. T., Willingham M. C., Pastan I., Howard B. H. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eucaryotic cells by DNA‐mediated transfection. Proc. Natl. Acad. Sci. (USA) 1982; 79: 6777–6781
   PubMed Web of Science ®Google Scholar
• Kerbel R. S. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. Adv. Cancer Res 1990; 55: 87–132
   PubMedGoogle Scholar
• Keski‐Oja J., Moses H. L. Growth inhibitory poly‐peptides in the regulation of cell proliferation. Med. Biol 1987; 65: 13–20
   PubMedGoogle Scholar
• Kim S. J., Denhez F., Kim K. Y., Holt J. T., Sporn M. B., Roberts A. B. Activation of the second promoter of the transforming growth factor pl gene by transforming growth factor β1 and phorbol ester occurs through the same target sequences. J. Biol. Chem 1989a; 264: 19373–19378
   PubMed Web of Science ®Google Scholar
• Kim S. J., Jeang K. T., Glick A. B., Sporn M. B., Roberts A. B. Promoter sequences of the human transforming growth factor β1 gene responsive to transforming growth factor β1 autoinduction. J. Biol. Chem 1989b; 264: 7041–7045
   PubMed Web of Science ®Google Scholar
• Kim S. J., Glick A., Sporn M. B., Roberts A. B. Characterization of the promoter region of the human transforming growth factor β1 gene. J. Biol. Chem 1989c; 264: 402–408
   PubMed Web of Science ®Google Scholar
• Kimchi A., Wang X. ‐F., Weinberg R. A., Cheifetz S., Massague J. Absence of TGF‐β receptors and growth inhibitory responses in retinoblastoma cells. Science 1988; 240: 196–198
   PubMed Web of Science ®Google Scholar
• Knabbe C., Lippman M. E., Wakefield L. M., Flanders K. C., Kasid A., Derynck R., Dickson R. B. Evidence that transforming growth factor‐β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417–428
   PubMed Web of Science ®Google Scholar
• Knabbe C., Zugmaier G., Dickson R. B., Lippman M. E. 3rd Proc. Int. Cong. Horm. Cancer. Hamburg 1988
   Google Scholar
• Lawrence D. A., Pircher R., Jullien P. Conversion of a high molecular weight latent β‐TGF from chicken embryo fibroblasts into a low molecular weight active β‐TGF under acidic conditions. Biochem. Biophys. Res. Commun 1985; 133: 1026–1034
   PubMed Web of Science ®Google Scholar
• Lyons R. M., Keski‐Oja J., Moses H. L. Proteolytic activation of latent transforming growth factor‐β from fibroblast‐conditioned medium. J. Cell Biol 1988; 106: 1659–1665
   PubMed Web of Science ®Google Scholar
• Masui T., Wakefield L. M., Lechner J. F., LaVeck M. A., Sporn M. B., Harris C. C. Type β transforming growth factor is the primary differentiation‐inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. (USA) 1986; 83: 2438–2442
   PubMed Web of Science ®Google Scholar
• Miyazono K., Hellman U., Wernstedt C., Heldin C. ‐H. Latent high molecular weight complex of transforming growth factor β1. J. Biol. Chem 1988; 263: 6407–6415
   PubMed Web of Science ®Google Scholar
• Moses H. L., Tucker R. F., Leof E. B., Coffey R. J., Jr., Halper J., Shipley G. D. Type‐β transforming growth factor is a growth stimulator and a growth inhibitor. Cancer Cells, J. Feramisco, B. Ozanne, C. Stiles. Cold Spring Harbor Laboratory, New York 1985; 65–71
   Google Scholar
• Hoda K., Umeda M., Ono T. Transforming growth factor activity in human colostrum. Gann 1984; 75: 109–112
   PubMedGoogle Scholar
• Nowell P. C. The clonal evolution of tumor cell populations. Science 1976; 194: 23–28
   PubMed Web of Science ®Google Scholar
• Pfarr D. S., Sathe G., Reff M. E. A highly modular cloning vector for the analysis of eucaryotic genes and gene regulatory elements. DNA 1985; 4: 461–467
   PubMedGoogle Scholar
• Roberts A. B., Anzano M. A., Wakefield L. M., Roche N. S., Stern D. F., Sporn M. B. Type β transforming growth factor: a bifunctional regulation of cellular growth. Proc. Natl. Acad. Sci. (USA) 1985; 82: 119–123
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B. Transforming growth factor‐β. Adv. Cancer Res 1988; 51: 107–145
   PubMed Web of Science ®Google Scholar
• Rosenthal A., Lindquist P. B., Bringman T. S., Goeddel D. V., Derynck R. Expression in rat fibroblasts of a human transforming growth factor‐α cDNA results in transformation. Cell 1986; 46: 301–309
   PubMed Web of Science ®Google Scholar
• Ruscetti C. CIBA Foundation Symposium 1991; 113: 212–231
   Google Scholar
• Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain‐terminating inhibitors. Prac. Natl. Acad. Sci. (USA) 1977; 74: 5463–5467
   PubMedGoogle Scholar
• Sato Y., Rifkin D. B. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor‐β1‐like molecule by plasmin during co‐culture. J. Cell. Biol 1989; 109: 309–315
   PubMed Web of Science ®Google Scholar
• Schwarz L. C., Gingras M. ‐C., Goldberg G., Greenberg A. H., Wright J. A. Loss of growth factor dependence and conversion of transforming growth factor‐β inhibition to stimulation in metastatic H‐ras‐transformed murine fibroblasts. Cancer Res 1988; 48: 6999–7003
   PubMedGoogle Scholar
• Schwarz L. C., Wright J. A., Gingras M. ‐C., Kondaiaif P., Danielpour D., Pimentel M., Sporn M. G., Greenberg A. H. Aberrant TGF‐β production and regulation in metastatic malignancy. Growth Factors 1990; 3: 115–127
   PubMedGoogle Scholar
• Schor S. L., Schor A. M., Durning P., Rushton G. Skin fibroblasts obtained from cancer patients display fetal‐like behavior on collagen gels. J. Cell Science 1985; 73: 235–244
   PubMed Web of Science ®Google Scholar
• Sha X., Bruuner A. M., Purchio A. F., Gentry L. E. Transforming growth factor β1: importance of glycosylation and acidic proteases for processing and secretion. Mol. Endocrinol 1989; 3: 1090–1098
   PubMedGoogle Scholar
• Silberstein G. B., Daniel C. W. Reversible inhibition of mammary gland growth by transforming growth factor‐beta. Science 1987; 237: 291–295
   PubMedGoogle Scholar
• Simonsen C. C., Levinson A. D. Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci. (USA) 1983; 80: 2495–2499
   PubMed Web of Science ®Google Scholar
• Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under the control of the SV40 early region promoter. J. Mol. Appl. Gen 1982; 1: 327–341
   PubMedGoogle Scholar
• Sporn M. B., Roberts A. B. Autocrine growth factors and cancer. Nature 1985; 303: 745–747
   Google Scholar
• Stern D. F., Hare D. L., Cecchini M. A., Weinberg R. A. Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science 1987; 235: 321–324
   PubMed Web of Science ®Google Scholar
• Theodorescu D., Fernandez B., Cornil I., Kerbel R. S. Overexpression of normal and mutated forms of c‐Ha‐ras induce orthotopic bladder invasion in a human superficial transitional cell carcinoma. Proc. Natl. Acad. Sci. (USA) 1990; 87: 9047–9051
   PubMed Web of Science ®Google Scholar
• Theodorescu D., Caltabiano M., Greig R., Rieman D., Waghorne C., Kerbel R. S. Reduction of TGF‐beta activity abrogates growth promoting tumor cell‐cell interactions in vivo. J. Cell Physiol 1991a, in press
   PubMedGoogle Scholar
• Theodorescu D., Cornil I., Sheehan C., Man S., Kerbel R. S. Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread. Int. J. Cancer 1991b; 47: 118–123
   PubMedGoogle Scholar
• Tsuji T., Okada F., Yamaguchi K., Nakamura T. Molecular cloning of the large subunit of transforming growth factor type betas masking protein and expression of the mRNA in various rat tissues. Proc. Natl. Acad. Sci 1990; 87: 8835–8839
   PubMed Web of Science ®Google Scholar
• Valverius E. M., Walker‐Jones D., Bates S. E., Stampfer M. R., Clark R., McCormick F., Dickson R. B., Lippman M. E. Production of and responsiveness to transforming growth factor‐β in normal and oncogene‐transformed human mammary epithelial cells. Cancer Res 1989; 49: 19203–6274
   Google Scholar
• Vonderhaar B. K. Breast Cancer: Cellular and Molecular Biology, M. E. Lippman, R. B. Dickson. Kluwer, Boston 1988; 251–266
   Google Scholar
• Wakefield L. M., Smith D. M., Masui T., Harris C. C., Sporn M. B. Distribution and modulation of the cellular receptor for transforming growth factor‐beta. J. Cell Biol 1987; 105: 965–975
   PubMed Web of Science ®Google Scholar
• Wakefield L. M., Smith D. M., Broz S., Jackson M., Levison A. D., Sporn M. B. Recombinant TGF‐β1 is synthesized as a two component latent complex that shares some structural features with the native platelet latent TGF‐β1 complex. Growth Factors 1989; 263: 6407–6415
   Google Scholar
• Walker‐Jones D., Valverius E. M., Stampfer M. S., Clarke R., McCormick F., Lippman M. E., Dickson R. B. Proc. Ann. Meet. Assoc. Cancer Res 1988; 249, (Abstract)
   Google Scholar
• Wang J. L., Hsu Y. M. Isolation and characterization of a growth regulatory factor from 3T3 cells. Prog. Clin. Biol. Res 1986; 217A: 393–396
   PubMedGoogle Scholar
• Wood W. I., Gitschier J., Lasky L. A., Lawn R. M. Base composition‐independent hybridization in tetro‐methylammonium chloride: A method for oligonucleotide screening of highly complex gene libraries. Proc. Natl. Acad. Sci. (USA) 1985; 82: 1585–1588
   PubMed Web of Science ®Google Scholar